ATE116656T1 - Säurebeständige dideoxynucleoside, wirksam gegen den hiv-virus. - Google Patents

Säurebeständige dideoxynucleoside, wirksam gegen den hiv-virus.

Info

Publication number
ATE116656T1
ATE116656T1 AT88303248T AT88303248T ATE116656T1 AT E116656 T1 ATE116656 T1 AT E116656T1 AT 88303248 T AT88303248 T AT 88303248T AT 88303248 T AT88303248 T AT 88303248T AT E116656 T1 ATE116656 T1 AT E116656T1
Authority
AT
Austria
Prior art keywords
dideoxynucleosides
resistant
acid
effective against
hiv virus
Prior art date
Application number
AT88303248T
Other languages
English (en)
Inventor
Victor E Marquez
John S Driscoll
Christopher Kuo-Hou Tseng
Nih C
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE116656T1 publication Critical patent/ATE116656T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88303248T 1987-04-17 1988-04-12 Säurebeständige dideoxynucleoside, wirksam gegen den hiv-virus. ATE116656T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3940287A 1987-04-17 1987-04-17

Publications (1)

Publication Number Publication Date
ATE116656T1 true ATE116656T1 (de) 1995-01-15

Family

ID=21905250

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88303248T ATE116656T1 (de) 1987-04-17 1988-04-12 Säurebeständige dideoxynucleoside, wirksam gegen den hiv-virus.

Country Status (9)

Country Link
EP (1) EP0287313B1 (de)
JP (2) JPH0613547B2 (de)
AT (1) ATE116656T1 (de)
AU (1) AU603219B2 (de)
CA (1) CA1340645C (de)
DE (1) DE3852665T2 (de)
HK (1) HK1007431A1 (de)
IL (1) IL86040A (de)
WO (1) WO1988007861A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides
US5644043A (en) * 1988-02-16 1997-07-01 Eli Lilly And Company 2',3'-dideoxy-2',2'-difluoronucleosides and intermediates
ATE128141T1 (de) * 1988-03-16 1995-10-15 Scripps Research Inst Als therapeutische mittel verwendbare substituierte adeninderivate.
JPH0232093A (ja) * 1988-06-08 1990-02-01 Merrell Dow Pharmaceut Inc 抗レトロウィルスジフルオロ化ヌクレオシド類
GB8816345D0 (en) * 1988-07-08 1988-08-10 Hoffmann La Roche Purine derivatives
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
US6207650B1 (en) 1989-05-15 2001-03-27 Bristol-Myers Squibb Company Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
GB8920534D0 (en) * 1989-09-11 1989-10-25 Wellcome Found Antiviral compounds
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
US5914396A (en) * 1990-01-11 1999-06-22 Isis Pharmaceuticals, Inc. 2'-O-modified nucleosides and phosphoramidites
US6399754B1 (en) 1991-12-24 2002-06-04 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides
US5872232A (en) * 1990-01-11 1999-02-16 Isis Pharmaceuticals Inc. 2'-O-modified oligonucleotides
US6005087A (en) * 1995-06-06 1999-12-21 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5670633A (en) * 1990-01-11 1997-09-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
US5859221A (en) * 1990-01-11 1999-01-12 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5792844A (en) * 1990-07-27 1998-08-11 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent nitrogen atoms
US5677437A (en) * 1990-07-27 1997-10-14 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US5623070A (en) 1990-07-27 1997-04-22 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5618704A (en) * 1990-07-27 1997-04-08 Isis Pharmacueticals, Inc. Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
US5610289A (en) * 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
US5420115A (en) * 1990-09-10 1995-05-30 Burroughs Wellcome Co. Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides
US5965722A (en) 1991-05-21 1999-10-12 Isis Pharmaceuticals, Inc. Antisense inhibition of ras gene with chimeric and alternating oligonucleotides
US7119184B2 (en) 1991-08-12 2006-10-10 Isis Pharmaceuticals, Inc. Oligonucleotides having A-DNA form and B-DNA form conformational geometry
US6307040B1 (en) 1992-03-05 2001-10-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
US9096636B2 (en) 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
WO2004044132A2 (en) 2002-11-05 2004-05-27 Isis Pharmaceuticals, Inc. Modified oligonucleotides for use in rna interference
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2928773A (en) * 1958-11-17 1960-03-15 It Prodotti Schering Soc Process for preparing inosine
JPS5686200A (en) * 1979-12-17 1981-07-13 Yamasa Shoyu Co Ltd Adenine nucleoside and its preparation
US4357824A (en) * 1980-09-15 1982-11-09 General Electric Company Method for determining volatilization rates of dissolved volatiles from solid waste materials
US4652554A (en) * 1982-02-22 1987-03-24 St. Jude Children's Research Hospital Nitro-substituted 1-β-D-arabinofuranosylcytosines
US4594339A (en) * 1982-04-06 1986-06-10 Sloan-Kettering Institute For Cancer Research Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides
US4489052A (en) * 1982-09-15 1984-12-18 Sloan-Kettering For Cancer Research Quantitative autoradiographic mapping of focal herpes simplex virus encephalitis using a radiolabeled antiviral drug
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
HU198393B (en) * 1984-03-06 1989-10-30 Sloan Kettering Inst Cancer Process for production of medical composition suitable for treatment of hepatitis containing as active substance derivatives of piramidin-nucleoside
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives

Also Published As

Publication number Publication date
JPH01501628A (ja) 1989-06-08
IL86040A0 (en) 1988-09-30
DE3852665D1 (de) 1995-02-16
AU603219B2 (en) 1990-11-08
DE3852665T2 (de) 1995-05-11
EP0287313A2 (de) 1988-10-19
JPH069680A (ja) 1994-01-18
EP0287313B1 (de) 1995-01-04
EP0287313A3 (en) 1989-06-14
JPH0613547B2 (ja) 1994-02-23
HK1007431A1 (en) 1999-04-09
CA1340645C (en) 1999-07-13
IL86040A (en) 1993-03-15
WO1988007861A1 (en) 1988-10-20
AU1684488A (en) 1988-11-04

Similar Documents

Publication Publication Date Title
ATE116656T1 (de) Säurebeständige dideoxynucleoside, wirksam gegen den hiv-virus.
RU96119782A (ru) Производные 7-амино-1h-индола
EA200100757A1 (ru) Хинолинкарбоксамиды в качестве противовирусных агентов
NO892381L (no) 1-indolylalkyl-4-(substituert-pyridinyl)piperaziner.
ATE68473T1 (de) 1-phenyl-3-naphthalenyloxy-propanamine.
EP0254902A3 (en) Solutions of oxazaphosphorins with enhanced stability and process for their preparation
SE8503415D0 (sv) Novel isoindolinyl-alkyl-piperazines
DE3879258D1 (de) Praeparat gegen ulcus.
FR2436779A1 (fr) Derives de pyrrolidine-2 methanol utilisables comme medicaments
MX9101059A (es) Composicion contra incrustaciones acuaticas
SE7709913L (sv) Sett att framstella penta peptider
UY23285A1 (es) Biocidas industriales, su uso y su preparacion
FI861934A0 (fi) Nya isoxazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
GB2021586A (en) 1,2,4-Triazolidin-3-ones (and -thiones)
ES445944A1 (es) Procedimiento de preparacion de derivados de 8-amino-teofi- lina.
ES2053530T3 (es) Compuestos macrolidos.
DE69203142D1 (de) Von l-Glutaminsäure abgeleitete Süssungsmittel, Verfahren zu ihrer Herstellung.
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
FI874585A (fi) Difenyleterherbicider.
RU94007089A (ru) Армированная полиолефиновая термопластическая композиция
SE8505534D0 (sv) Kemiska foreningar
EA199700188A1 (ru) Пестициды
IE792347L (en) Benzimidazole derivatives.
FR2366280A1 (fr) Nouvelles 1h-benzo(de)isoquinoleine-1,3(2h)-diones substituees en position 2, utiles comme agents anti-inflammatoires
DE69222438D1 (de) Aids-virus-infektion hemmende zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time